Smart Prostate Specific Antigen (PSA) Screening Study
Completed · Not applicable
Conditions studied: PSA, Prostate Cancer
In brief
This intervention includes the introduction of the Prostate Cancer Working Group (PCWG )Smart PSA Screening Guidelines and implementation of patient navigation/ care coordination for men with elevated PSA (\>4.0 ng/mL). The guidelines include: 1. What age to start? 2. How often to repeat screening? 3. What age to stop? 4. What PSA threshold should trigger a biopsy referral?
Key facts
- Study ID
- NCT04782713
- Run by
- University of Illinois at Chicago
- People needed
- 49
- Starts
- 2021-12-17
- Expected to finish
- 2024-11-15
- Last updated by the study team
- 2026-01-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- Mile Square Health Center — Chicago, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.